Jefferies Upgrades Arena Pharma (ARNA) to Buy
Tweet Send to a Friend
Get Alerts ARNA Hot Sheet
Price: $7.51 --0%
Rating Summary:
3 Buy, 8 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 7
Rating Summary:
3 Buy, 8 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 7
Trade ARNA Now!
Jefferies upgraded Arena Pharma (NASDAQ: ARNA) from Underperform to Buy, price target raised from $1 to $9.
For an analyst ratings summary and ratings history on Arena Pharma click here. For more ratings news on Arena Pharma click here.
Shares of Arena Pharma closed at $3.66 yesterday, with a 52 week range of $1.23-$3.89.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Arena Pharma click here. For more ratings news on Arena Pharma click here.
Shares of Arena Pharma closed at $3.66 yesterday, with a 52 week range of $1.23-$3.89.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Goldman Sachs Upgrades Tanger Factory Outlet Centers (SKT) to Neutral
- Keefe, Bruyette & Woods Upgrades Reinsurance Group of America (RGA) to Outperform
- VIVUS (VVUS) Qsymia Prescriptions Fall Ahead of Belviq Launch (ARNA)
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
